Disturbances in Brain-Heart Neuronal-Metabolic Axis Are Associated With Major Arrhythmic Events in Heart Failure

医学 心力衰竭 心脏病学 内科学
作者
Thomas H. Schindler,Ines Valenta,Vasken Dilsizian
出处
期刊:Journal of the American College of Cardiology [Elsevier BV]
卷期号:80 (20): 1897-1899 被引量:3
标识
DOI:10.1016/j.jacc.2022.09.014
摘要

Postmarketing evaluations have linked myocarditis to COVID-19 mRNA vaccines. However, few population-based analyses have directly compared the safety of the 2 mRNA COVID-19 vaccines.This study aimed to compare the risk of myocarditis, pericarditis, and myopericarditis between BNT162b2 and mRNA-1273.We used data from the British Columbia COVID-19 Cohort (BCC19C), a population-based cohort study. The exposure was the second dose of an mRNA vaccine. The outcome was diagnosis of myocarditis, pericarditis, or myopericarditis during a hospitalization or an emergency department visit within 21 days of the second vaccination dose. We performed multivariable logistic regression to assess the association between vaccine product and the outcomes of interest.The rates of myocarditis and pericarditis per million second doses were higher for mRNA-1273 (n = 31, rate 35.6; 95% CI: 24.1-50.5; and n = 20, rate 22.9; 95% CI: 14.0-35.4, respectively) than BNT162b2 (n = 28, rate 12.6; 95% CI: 8.4-18.2 and n = 21, rate 9.4; 95% CI: 5.8-14.4, respectively). mRNA-1273 vs BNT162b2 had significantly higher odds of myocarditis (adjusted OR [aOR]: 2.78; 95% CI: 1.67-4.62), pericarditis (aOR: 2.42; 95% CI: 1.31-4.46) and myopericarditis (aOR: 2.63; 95% CI: 1.76-3.93). The association between mRNA-1273 and myocarditis was stronger for men (aOR: 3.21; 95% CI: 1.77-5.83) and younger age group (18-39 years; aOR: 5.09; 95% CI: 2.68-9.66).Myocarditis/pericarditis following mRNA COVID-19 vaccines is rare, but we observed a 2- to 3-fold higher odds among individuals who received mRNA-1273 vs BNT162b2. The rate of myocarditis following mRNA-1273 receipt is highest among younger men (age 18-39 years) and does not seem to be present at older ages. Our findings may have policy implications regarding the choice of vaccine offered.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
精明寻梅发布了新的文献求助10
4秒前
量子星尘发布了新的文献求助50
4秒前
Liufgui应助哈哈哈来打我呀采纳,获得20
5秒前
绛川完成签到,获得积分10
5秒前
爆米花应助momo采纳,获得10
7秒前
动听的老鼠完成签到,获得积分10
7秒前
潘善若发布了新的文献求助10
7秒前
丘比特应助CA采纳,获得10
7秒前
8秒前
10秒前
111完成签到 ,获得积分10
10秒前
忧心的从蓉完成签到,获得积分10
11秒前
11秒前
李希妍完成签到,获得积分10
12秒前
迪克牛仔完成签到 ,获得积分10
12秒前
Jasper应助精明寻梅采纳,获得10
13秒前
米线儿完成签到,获得积分10
14秒前
甜桃完成签到,获得积分10
14秒前
14秒前
15秒前
CAOHOU应助q792309106采纳,获得10
15秒前
16秒前
16秒前
悦耳静枫发布了新的文献求助10
18秒前
烟花应助果粒多采纳,获得10
18秒前
潘善若发布了新的文献求助10
19秒前
廉凌波发布了新的文献求助10
19秒前
赘婿应助crazy采纳,获得10
19秒前
喻义梅关注了科研通微信公众号
20秒前
精明寻梅完成签到,获得积分10
20秒前
行远完成签到,获得积分10
21秒前
科目三应助感动黄豆采纳,获得10
22秒前
xueyu发布了新的文献求助10
22秒前
钱宇成完成签到,获得积分20
23秒前
修道院的豌豆完成签到,获得积分10
23秒前
廉凌波完成签到,获得积分10
24秒前
Rondab应助行远采纳,获得10
26秒前
26秒前
SYLH应助showmaker采纳,获得20
27秒前
27秒前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
‘Unruly’ Children: Historical Fieldnotes and Learning Morality in a Taiwan Village (New Departures in Anthropology) 400
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
基于可调谐半导体激光吸收光谱技术泄漏气体检测系统的研究 350
Robot-supported joining of reinforcement textiles with one-sided sewing heads 320
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3989263
求助须知:如何正确求助?哪些是违规求助? 3531418
关于积分的说明 11253814
捐赠科研通 3270066
什么是DOI,文献DOI怎么找? 1804884
邀请新用户注册赠送积分活动 882084
科研通“疑难数据库(出版商)”最低求助积分说明 809136